Valuation (83%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 3.06 | N/A |
| PEG Ratio (TTM) | -0.73 | N/A |
| P/S Ratio (TTM) | 1.30 | N/A |
| P/B Ratio (TTM) | 0.32 | N/A |
| P/FCF Ratio (TTM) | 18.48 | N/A |
| Price to 5YR AVG Earnings Ratio | 16.12 | N/A |
| Price to 5YR AVG FCF Ratio | 6.15 | N/A |
Profitability (55%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 8.96% | N/A |
| ROE (TTM) | 11.11% | N/A |
| Net Profit Margin (TTM) | 40.87% | N/A |
| ROIC 5YR AVG | 3.75% | N/A |
Growth (77%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 13.03% | 69.50% | 91.72% |
| Revenue | 4.40% | -2.70% | -2.49% |
| Net Income | 12.12% | 65.51% | 89.14% |
| Cash Flow | 28.82% | 9.79% | 21.58% |
Health (86%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.66 | N/A |
| Quick Ratio (TTM) | 2.59 | N/A |
| D/E Ratio (TTM) | 0.14 | N/A |
| Interest Coverage (TTM) | 5.55 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 2.17 | N/A |
| LTL to 5YR AVG FCF | 3.20 | N/A |
| Shares Outstanding Growth 5YR AVG | -1.25% | N/A |